Venous Thromboembolism Prophylaxis in Pediatric Inflammatory Bowel Disease Patients Hospitalized With a Central Line

被引:2
|
作者
Hamant, Laura G. [1 ]
Gonzalez-llanos, Lucia [1 ]
Patel, Ashish S. [1 ,2 ]
McMahon, Lisa [1 ,3 ]
Knoll, Christine [1 ,4 ]
Swing, Ted [1 ]
Pasternak, Brad [1 ,2 ,5 ]
机构
[1] Phoenix Childrens Hosp, Phoenix, AZ USA
[2] Phoenix Childrens Hosp, Dept Gastroenterol, Phoenix, AZ USA
[3] Phoenix Childrens Hosp, Dept Surg, Phoenix, AZ USA
[4] Phoenix Childrens Hosp, Dept Hematol Oncol, Phoenix, AZ USA
[5] Div Gastroenterol, 1919 E Thomas Rd, Phoenix, AZ 85016 USA
关键词
Crohn disease; deep vein thrombosis; enoxaparin; ulcerative colitis; RISK; THROMBOPROPHYLAXIS; PREVENTION; THROMBOSIS; CHILDREN;
D O I
10.1097/MPG.0000000000003747
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives:Patients hospitalized with inflammatory bowel disease (IBD) have increased risk of venous thromboembolism (VTE). The aim of this study was to determine whether the adoption of a VTE protocol would change rates of medical VTE prophylaxis (low molecular weight heparin) in patients with IBD and a central venous catheter (CVC), while subsequently decreasing the incidence of VTE in this population. Methods:A protocol for VTE prophylaxis in IBD was established in March of 2018. Every patient hospitalized with an IBD flare and central venous access from March 2013 to March 2020 was identified. Study data, including patient demographics, rates of Doppler ultrasound (US), and rates of VTE were collected using International Classification of Diseases (ICD)-10 codes, CPT codes, and chart review retrospectively. Determination of an IBD flare was based on physician global assessment. Groups were compared with independent-sample t tests and chi-squared tests. Results:A total of 313 hospitalizations across 187 different patients were identified that met criteria including IBD and central venous access. VTE prophylaxis increased from 5.24% (n = 12) prior to the intervention to 63.10% (n = 53) after the intervention [chi-square (1, N = 313) = 125.0192, P < 0.001]. Rate of Doppler US increased from 9.17% (n = 21) prior to the intervention to 17.86% (n = 15) after the intervention [chi-square (1, N = 313) = 4.5562, P < 0.05]. Diagnosis of VTE increased from 0.87% (n = 2) prior to the intervention to 7.14% (n = 6) after the intervention [chi-square (1, N = 313) = 9.6992, P < 0.01]. There were no significant differences in the demographic characteristics pre- versus post-intervention. Conclusions:Rates of Doppler US and VTE prophylaxis use increased significantly after implementation of a VTE protocol. Rates of VTE diagnosis also increased, though we suspect this may be due to missed diagnoses prior to implementation of the protocol and increased risk awareness after the protocol was established.
引用
收藏
页码:610 / 615
页数:6
相关论文
共 50 条
  • [21] Venous Thromboembolism Risk in Patients With Inflammatory Bowel Disease: Defining the Benefits of Pharmacologic Prophylaxis
    Sultan, Keith
    Brun, Alexander
    Spyropoulos, Alex C.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (09) : 1577 - 1577
  • [22] Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease
    Faye, Adam S.
    Hung, Kenneth W.
    Cheng, Kimberly
    Blackett, John W.
    Mckenney, Anna Sophia
    Pont, Adam R.
    Li, Jianhua
    Lawlor, Garrett
    Lebwohl, Benjamin
    Freedberg, Daniel E.
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 (09) : 1394 - 1400
  • [23] IMPROVING VENOUS THROMBOEMBOLISM PROPHYLAXIS IN HOSPITALIZED PEDIATRIC PATIENTS: A QI INITIATIVE
    Wolfe, Danielle
    Abuso, Stephanie
    Jasinski, Sylwia
    Asuncion, Arsenia
    Quintos-Alagheband, Maria Lyn
    Tuan Nguyen
    Thomas, Dinah
    Grella, Melissa
    Noiman, Ashley
    Canter, Marguerite
    [J]. PEDIATRIC BLOOD & CANCER, 2022, 69
  • [24] An Electronic Alert System Is Associated With a Significant Increase in Pharmacologic Venous Thromboembolism Prophylaxis Rates in Hospitalized Inflammatory Bowel Disease Patients
    Mathers, Bradley
    Williams, Emmanuelle
    Bedi, Gurneet
    Tinsley, Andrew
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S378 - S378
  • [25] Venous Thromboembolism in Pediatric Inflammatory Bowel Disease: A Scoping Review
    Gandhi, Jermie
    Mages, Keith
    Kucine, Nicole
    Chien, Kimberley
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (04): : 491 - 498
  • [26] VENOUS THROMBOEMBOLISM IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A SCOPING REVIEW
    Gandhi, Jermie
    Mages, Keith
    Chien, Kimberley
    Kucine, Nicole
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E38 - E39
  • [27] Venous thromboembolism prophylaxis in inflammatory bowel disease flare-ups
    Kaddourah, Osama
    Numan, Laith
    Jeepalyam, Sravan
    Abughanimeh, Omar
    Abu Ghanimeh, Mouhanna
    Abuamr, Khalil
    [J]. ANNALS OF GASTROENTEROLOGY, 2019, 32 (06): : 578 - 583
  • [28] INCREASING PREVALENCE OF VENOUS THROMBOEMBOLISM IN HOSPITALIZED INFLAMMATORY BOWEL DISEASE: TREND SINCE GUIDELINE RECOMMENDED PHARMACOLOGIC PROPHYLAXIS
    Rotundo, Laura
    Hajjar, Richard A.
    Sultan, Keith S.
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S412 - S413
  • [29] Preventability of Venous Thromboembolism in Patients with Inflammatory Bowel Disease
    Scoville, Elizabeth
    Konijeti, Gauree
    Yajnik, Vijay
    Nguyen, Deanna
    Sauk, Jenny
    Ananthakrishnan, Ashwin
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S511 - S512
  • [30] Venous thromboembolism in Asian patients with inflammatory bowel disease
    Lin, H.
    Lim, W. C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S311 - S312